Driving cost, process, and operational efficiencies with MiMode PuraBead® HX2 Efficiency is a defining priority in modern biomanufacturing, where cost, process, and operational gains directly impact scalability and success. This white paper explores the critical role of purification efficiency, introducing MiMode PuraBead® HX2 as a compelling alternative to Protein L. Designed for antibody fragments and bispecific antibodies, MiMode PuraBead® HX2 combines broad specificity, fast flow performance, and robust chemical stability to drive down costs and streamline downstream operations.
In the biopharmaceutical industry, purification remains one of the most critical steps influencing cost of goods (COGs), process efficiency, and scalability. As the therapeutic landscape continues to evolve toward more complex modalities like bispecific antibodies (bsAbs), the need for more adaptable and cost-effective purification platforms has never been more urgent. The drive toward lower manufacturing costs and improved process economics is forcing a re-evaluation of capture technologies. Efficiency in bioprocessing now encompasses several key performance categories, including cost, process, and operational efficiencies. Lowering the material cost per gram of purified product, along with minimizing expenditures on consumables, buffer solutions, and labor, can significantly impact overall cost, particularly in high-volume bioreactor settings or when using intensified processing strategies. By reducing resin costs, optimizing buffer usage, and limiting auxiliary requirements such as unique cleaning operations or storage infrastructure, organizations can reduce their COGs while improving predictability and financial control. Increasing throughput and yield, reducing processing time, and improving impurity removal are central to process efficiencies, especially for complex biologics which demand purification strategies that balance sensitivity and robustness. Resins that support fast flow rates and short cycle durations enable higher productivity and better product quality, supporting faster batch release and smoother regulatory alignment. A modern, efficient process is not only about throughput, however. It is also about establishing a reliable, reproducible, and scalable platform that can transition seamlessly from
MiMode PuraBead® HX2 HF delivers cost-efficiency compared to market leading Protein L resin
• Lower resin cost per gram of product • High recovery, higher purity • Pay less, purify more
But cost-efficiency is just the beginning • Comparable yield recovery, with higher impurity removal • Ultra-stable ligand designed for robustness and reproducibility • Simplified CIP with full stability in 1 M NaOH (unlike others limited to 0.1 M) • Straightforward analytics compatible with standard LC/MS workflows • Over 200 reuse cycles, with no need for cold storage • No immunogenic leachables, making it ideal for sensitive biologics
Figure 1: Cost and operational efficiencies of using MiMode PuraBead® HX2 F1P HF over Protein L. lab to commercial scale. Streamlining procedures, ensuring compatibility with stringent cleaning protocols, simplifying logistics, and maintaining high product consistency are essential for operational efficiency. This includes minimizing hands-on maintenance, using robust materials resistant to harsh chemicals, and selecting resins that perform consistently
astreabioseparations.com